Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19)

The publication summarizes multiple areas of focus:

  • Myocardial Injury measured by multiple myocardial and inflammatory markers increases mortality risk – Higher enzyme values = higher mortality.
  • Myocardial markers which stabilized or declined were associated with a lower mortality risk consistent with the importance of aggressive management.
  • Patients with elevated cardiac markers (e.g. Troponin T) and a history of CV disease had nearly twice the mortality risk (69.4%) compared to patients with elevated cardiac markers but no history of CV disease (37.5%).